


產品信息
| 名稱 | NCCIT (人畸胎癌細胞) (STR鑒定正確) |
| 別稱 | NCC-IT |
| 背景描述 | NCCIT was established by Shinichi Teshima (National Cancer Institute, Tokyo, Japan) in 1985 from a mediastinal mixed germ cell tumor. |
| 種屬 | 人 |
| 年齡(性別) | 男;24歲 |
| 組織來源 | 多能性胚胎癌;畸胎癌 |
| 生長特性 | 貼壁細胞 |
| 細胞形態 | 上皮細胞樣 |
| 細胞類型 | 腫瘤細胞 |
| 腫瘤類型 | 畸胎癌細胞 |
| 生物安全等級 | 1 |
| 生長培養基 | RPMI-1640+10% FBS+1%P/S |
| 推薦傳代比例 | 1:4-1:8 |
| 推薦換液頻率 | 2~3次/周 |
| 凍存條件 | 凍存液:55% 基礎培養基+40%FBS+5%DMSO溫度:液氮 |
| 培養條件 | 氣相:空氣,95%;CO2,5%溫度:37℃ |
| 致瘤性 | Yes, Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 107 cells. |
| 保藏機構 | ATCC; CRL-2073 |
STR位點信息
| Amelogenin | X |
| CSF1PO | 10,12 |
| D2S1338 | 18,19 |
| D3S1358 | 16 |
| D5S818 | 10,13 |
| D7S820 | 10 |
| D8S1179 | 10,15 |
| D13S317 | 11 |
| D16S539 | 9,12 |
| D18S51 | 13,14 |
| D19S433 | 13,15 |
| D21S11 | 29,32.2 |
| FGA | 22,26 |
| PentaD | 10,12 |
| PentaE | 5,14 |
| TH01 | 7,9 |
| TPOX | 8 |
| vWA | 14,18 |
| D6S1043 | 14 |
| D12S391 | 18,22 |
| D2S441 | 11,14 |